ERBB2 and breast carcinoma: Interestingly, an alternative and increasingly explored approach to overcome host T cell exhaustion is based on simultaneously engaging innate immune cells activators, like CD16 in natural killer cells and macrophages, along with tumour-related antigens such as HER2 in ovarian and breast cancer cells (81).